Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

TriSalus Life Sciences, Inc.

NASDAQ: TLSI · Industrial Applications and Services · 4 alerts · CIK 1826667

Share price
$2.27Close, Nov 16
Market cap
$140M
Shares outstanding
61.7MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All TriSalus Life Sciences, Inc. filings on SEC EDGAR ↗

8:09 AM ET 10-Q
Financial Results

TriSalus Life Sciences Q3 2026 Results: Net Loss of $8.85M, Loss Narrows

TriSalus Life Sciences reported a net loss of $16.5 million for the nine months ended September 30, 2026, an improvement from a $29.5 million loss in the prior year period. Revenue grew to $33.2 million, while the company strengthened its balance sheet with cash and cash equivalents increasing to $41.1 million.

Key figure
Net loss $8.85M
8:07 AM ET 8-K
Financial Results

TriSalus Life Sciences Financial Results

TriSalus Life Sciences reported Q3 2026 revenue of $12.9 million, representing 11.3% year-over-year growth driven by increased TriNav unit sales. The company revised its full-year 2026 revenue guidance to a range of $46 million to $48 million and highlighted recent FDA clearance for its TriNav Advance system.

“The third quarter marked an important period of growth and expansion for TriSalus – we drove double-digit year-over-year growth and received FDA clearance for TriNav Advance, which enables Pressure-Enabled Drug Delivery to small distal vessels through the microcatheter of the physician’s choice.”

Mary Szela, President and Chief Executive Officer

“Looking ahead, we believe we are well positioned for 2027. We more than doubled our commercial footprint over the first half of the year, and although our team productivity has ramped slightly slower than anticipated, our representatives continue to educate and drive further TriNav utilization as they build and strengthen relationships with interventional radiologists.”

Mary Szela, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.